HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.53B |
| 2 |
Apple
AAPL
|
+$1.24B |
| 3 |
NVIDIA
NVDA
|
+$1.17B |
| 4 |
Flutter Entertainment
FLUT
|
+$1.11B |
| 5 |
Amazon
AMZN
|
+$859M |
Top Sells
| 1 |
Cognizant
CTSH
|
+$298M |
| 2 |
Stellantis
STLA
|
+$156M |
| 3 |
Bank of America
BAC
|
+$143M |
| 4 |
Dollar Tree
DLTR
|
+$110M |
| 5 |
iShares Global Energy ETF
IXC
|
+$85.5M |
Sector Composition
| 1 | Technology | 29.95% |
| 2 | Financials | 12.5% |
| 3 | Healthcare | 11.46% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TELL
2526
DELISTED
Tellurian Inc.
TELL
| $43K | ﹤0.01% |
+64,997
| New | +$43K |
|
|
NGD
2527
New Gold Inc
NGD
$5.14B
| $42K | ﹤0.01% |
25,053
| – | – |
|
2528
Vor Biopharma
VOR
$228M
| $42K | ﹤0.01% |
+17,705
| New | +$42K |
|
2529
Gannett
GCI
$601M
| $41.7K | ﹤0.01% |
+17,104
| New | +$41.7K |
|
|
ADAP
2530
Adaptimmune Therapeutics
ADAP
$13.5M
| $41.2K | ﹤0.01% |
26,064
-440
| -2% | -$695 |
|
|
URG
2531
Ur-Energy
URG
$547M
| $40K | ﹤0.01% |
25,000
| – | – |
|
2532
Lyell Immunopharma
LYEL
$251M
| $40K | ﹤0.01% |
+896
| New | +$40K |
|
2533
Angi Inc
ANGI
$769M
| $40K | ﹤0.01% |
1,525
| – | – |
|
|
TGB
2534
Taseko Mines
TGB
$1.08B
| $39.9K | ﹤0.01% |
+19,135
| New | +$39.9K |
|
2535
Kaltura
KLTR
$255M
| $39.8K | ﹤0.01% |
29,508
+9,602
| +48% | +$13K |
|
2536
GrafTech
EAF
$199M
| $38.8K | ﹤0.01% |
2,815
+1,508
| +115% | +$20.8K |
|
2537
NextCure
NXTC
$14.7M
| $38.7K | ﹤0.01% |
1,447
| – | – |
|
2538
AST SpaceMobile
ASTS
$10.1B
| $37.7K | ﹤0.01% |
+13,007
| New | +$37.7K |
|
|
NXDR
2539
Nextdoor Holdings
NXDR
$771M
| $37.5K | ﹤0.01% |
+16,664
| New | +$37.5K |
|
2540
Solid Power
SLDP
$645M
| $36.2K | ﹤0.01% |
+17,823
| New | +$36.2K |
|
2541
ChargePoint
CHPT
$235M
| $35.5K | ﹤0.01% |
+934
| New | +$35.5K |
|
2542
Arbutus Biopharma
ABUS
$886M
| $35K | ﹤0.01% |
+13,548
| New | +$35K |
|
|
AGEN
2543
Agenus
AGEN
$154M
| $33.9K | ﹤0.01% |
2,923
+2,188
| +298% | +$25.4K |
|
|
DADA
2544
DELISTED
Dada Nexus
DADA
| $33.8K | ﹤0.01% |
+16,573
| New | +$33.8K |
|
2545
OppFi
OPFI
$289M
| $33.7K | ﹤0.01% |
+13,490
| New | +$33.7K |
|
|
VNET
2546
VNET Group
VNET
$2.13B
| $33.6K | ﹤0.01% |
21,681
+10,556
| +95% | +$16.4K |
|
|
EVA
2547
DELISTED
Enviva Inc.
EVA
| $33.5K | ﹤0.01% |
76,015
+27,646
| +57% | +$12.2K |
|
2548
Erasca
ERAS
$440M
| $32.2K | ﹤0.01% |
+15,619
| New | +$32.2K |
|
2549
Quantum-Si Incorporated
QSI
$227M
| $32K | ﹤0.01% |
+16,260
| New | +$32K |
|
2550
Coca-Cola Femsa
KOF
$17.8B
| $31.4K | ﹤0.01% |
323
| – | – |
|